RxDoctor Payments DataLook up a doctor →

Rex Mowat, MD

Hematology & Oncology · Toledo, OHNPI 1346247251

Payments from drug & device makers

$1,214,817in general payments, 2019–2025

Across 738 payments — averaging $1646.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Seagen Inc.$309K
  • AbbVie$157K
  • Astrazeneca UK Limited$78K
  • Daiichi Sankyo Inc.$69K
  • Genentech, Inc.$69K
  • Pfizer$53K
  • plus $480K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Seagen Inc.126$308,790
AbbVie62$157,160
Astrazeneca UK Limited2$78,234
Daiichi Sankyo Inc.51$69,030
Genentech, Inc.28$68,518
Pfizer21$52,853
Eli Lilly3$45,944
Cornerstone Specialty Network LLC47$42,609
Novocure Inc.20$37,535
Helsinn Healthcare SA14$34,110
Ipsen Bioscience Inc.7$32,966
Tesaro, Inc.3$31,953
TG Therapeutics, Inc.30$29,600
Radius Health, Inc.17$27,167
Amgen14$22,397
Veru Inc.6$20,000
GSK6$19,197
Hexal AG9$16,723
E.r. Squibb & Sons, L.L.C.13$15,664
EMD Serono, Inc.11$13,340
Verastem, Inc.20$13,122
Astellas Pharma Global Development10$12,925
Pharmacyclics LLC, An Abbvie Company23$10,250
Beigene, Ltd.1$8,808
Merck35$8,516
Janssen Research & Development, LLC5$7,250
Bausch Health US, LLC1$6,500
Bristol Myers Squibb13$5,300
Mirati Therapeutics, Inc.4$4,250
Bayer7$3,898
Sanofi US Services Inc.2$2,600
Stemline Therapeutics Inc.3$2,235
Geron Corporation1$960
Incyte Corporation6$775
AstraZeneca15$551
Johnson & Johnson12$309
Sanofi7$301
Foundation Medicine, Inc.1$300
Novartis14$285
Tempus AI, Inc5$260
Takeda Pharmaceuticals U.S.A., Inc.5$180
Gilead(2 entities)8$147
Astellas Pharma US Inc7$131
Genmab U.S., Inc.1$118
Dova Pharmaceuticals1$92
Ipsen Biopharmaceuticals, Inc1$75
Varian Medical Systems, Inc.1$71
Eisai Inc.4$68
Adaptive Biotechnologies Corporation3$66
Genentech USA, Inc.4$64
Lilly USA, LLC3$60
Beone Medicines USA, Inc.2$60
Elekta, Inc.1$58
Agios Pharmaceuticals, Inc.2$55
G1 Therapeutics, Inc.3$46
Rigel Pharmaceuticals, Inc.3$45
Morphosys, US Inc.2$41
Dendreon Pharmaceuticals LLC1$35
Regeneron Healthcare Solutions, Inc.2$34
Tersera Therapeutics LLC1$30

How this compares

$1,214,817 in reported general payments places this provider in the 90th percentile of 450 hematology & oncology providers in Ohio.

See all hematology & oncology providers in Ohio →

Medicare billing

Part B allowed, 2024
$3,201,035
Medicare patients
695
Services billed
166,452

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Toledo

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →